#cancerresearch

The FDA approved daraxonrasib for defined groups of adults with metastatic pancreatic adenocarcinoma after a 500-person trial doubled median survival versus chemotherapy. The once-daily RAS inhibitor is not a cure, carries serious risks and has a list price near $39,800 per month. A Pancreatic Cancer Drug That Doubled Median Survival Is Now Approved

Cleveland Clinic Abu Dhabi has introduced the region’s first robotically assisted bronchoscopy platform, designed to help doctors reach small, difficult lung nodules for biopsy. The launch could shorten the path to diagnosis, but the hospital has not yet published local patient numbers or outcome data. Abu Dhabi Introduces the Middle East’s First Robotic System for Deep Lung Biopsies

Researchers coated cancer cells with bacterial signals that prompted macrophages to recognize and engulf them, raising phagocytosis from about 20% to 70% in laboratory tests and slowing tumours in mice. The approach is inventive, but it remains preclinical and has not been tested for safety or effectiveness in people. Scientists Made Cancer Cells Look Like Bacteria So Immune Cells Would Eat Them

An international study of more than 600 childhood tumours identified mutation patterns linked to specific cancer treatments, sometimes within 91 days. The findings may support earlier monitoring of resistant disease, but they do not show that chemotherapy causes every relapse or provide a clinical test yet. Chemotherapy Can Leave a DNA Fingerprint in Childhood Tumours Within Months